Ian Clements
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ian Clements
Ian Clements was last confirmed as CFO at Mirum Pharmaceuticals, Inc. (MIRM) in a filing dated April 22, 2022. The proxy statement of Mirum Pharmaceuticals, Inc. reports total compensation of $1,389,494 for Ian Clements in fiscal 2020, including a base salary of $378,390. Ian Clements has spoken on 8 earnings calls across 1 company, most recently for Mirum Pharmaceuticals, Inc. on January 9, 2023.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2022-04-22
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Financial Officer | $378,390 | $1,389,494 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.